Latest News
|
24 May 2013
0 Likes 
Hello and welcome to a new edition of Five out of Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week covered by a publication other than
Read More...
Latest News
|
24 May 2013
0 Likes
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.EMA to Phase out Non-Electronic
Read More...
Latest News
|
24 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. Focus will be observing Memorial Day in the US on 27 May and will resume normal operations on 28 May.In
Read More...
Latest News
|
23 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US FDA panel backs limited rollout of Merck's sleep drug suvorexant (Fierce) (The Pink Sheet)
Read More...
Latest News
|
22 May 2013
1 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Accuracy of Blood Glucose Meters Draws FDA Scrutiny (KHN) (Medical Daily) Law Firm: FDA's
Read More...
Latest News
|
21 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Merck Insomnia Drug Suvorexant Safer at Lower Dose, FDA Staff Says (Bloomberg) (Reuters)
Read More...
Latest News
|
20 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US NYTimes Reports Chinese Hackers Going After, Among Other Things, Clinical Trials Results
Read More...
Latest News
|
17 May 2013
0 Likes
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA's Big Week for Device Guidance and
Read More...
Latest News
|
17 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Is the Hatch-Waxman Act Flawed and Should the Supreme Court Fix It? (Becker's Hospital
Read More...
Latest News
|
16 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: Special Edition Dirty Medicine: The Epic Story of Criminal Fraud at Ranbaxy (Fortune)
Read More...